Medication info
Pari Wonjeong 10 mg (Rabeprazole Sodium)

Pari Wonjeong 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
For domestic use - 28 tablets/box [14 tablets/Alu Alu packaging x 2]
Approval status
Active

MFDS item code 201906769 · Approved 2019.09.25 · Insurance code 057600230

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the patient has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled using an on-demand regimen of 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults: Since hepatic function is often decreased, administer with caution.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat ulcers in the stomach and duodenum. It also improves erosions or ulcers caused by gastroesophageal reflux disease and is effective in alleviating symptoms. Long-term maintenance therapy for gastroesophageal reflux disease can prevent recurrence. For patients with gastrointestinal ulcers due to Helicobacter pylori infection, it is used in conjunction with antibiotics to enhance therapeutic effectiveness. Additionally, it aids in the treatment of acid-related disorders such as Zollinger-Ellison syndrome. This medication is used to improve various symptoms across gastrointestinal diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the patient has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled using an on-demand regimen of 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Older adults: Since hepatic function is often decreased, administer with caution.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used by patients who have allergies or a history of hypersensitivity to certain ingredients or medications. Women who are pregnant or breastfeeding should not take this medication, and it should be used with caution in patients with impaired liver function or elderly patients. If allergy symptoms such as rash, itching, or hives occur during treatment, stop taking the medication immediately and consult a doctor. Regular blood tests and liver function tests should be conducted, and appropriate action should be taken if abnormalities are found. Various side effects can occur in different parts of the body including the heart, digestive system, nervous system, respiratory system, skin, eyes, and urogenital system, so patients should be informed if any symptoms arise. Long-term use may increase the risk of osteoporosis and fractures, so caution is advised, and regular monitoring of magnesium levels is recommended. This medication strongly suppresses gastric acid secretion, which may slightly increase the risk of bacterial infections in the gastrointestinal tract. Drowsiness or dizziness may occur, so caution is required when driving or operating machinery. There may be drug interactions, so especially when taken with medications affecting blood coagulation, antibiotics, or antiviral agents, consultation with a doctor is necessary. This medication should be swallowed whole and should not be chewed or crushed, and it must be kept out of reach of children. There is no specific antidote for overdose, so appropriate treatment should be administered according to the symptoms.

Side effects

Rash, hives, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, increased ALT, increased AST, increased ALP, increased γ-GTP, increased LDH, increased total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, atrioventricular block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric lesions, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenitis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, neuroexcitability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, sensory numbness, decreased grip strength, language confusion, staggering, delirium, disorientation, narcolepsy, cough, pharyngitis, rhinitis, shortness of breath, asthma, nosebleeds, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, excessive muscle tension, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, increased thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fracture, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, discoid lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

For domestic use - 28 tablets/box [14 tablets/Alu Alu packaging x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.